This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
HempMeds Brasil
HempMeds Brasil, a leading name in the hemp-derived products industry, is headquartered in Brazil and operates extensively across the region. Founded in 2016, the company has established itself as a pioneer in the production and distribution of high-quality cannabidiol (CBD) products, catering to the growing demand for natural wellness solutions. Specialising in a diverse range of offerings, including CBD oils, capsules, and topical applications, HempMeds Brasil stands out for its commitment to quality and transparency. The company utilises advanced extraction methods to ensure the purity and potency of its products, making them a trusted choice for consumers seeking natural alternatives. With a strong market presence and a reputation for excellence, HempMeds Brasil continues to lead the way in the hemp industry, contributing to the evolving landscape of health and wellness in Brazil and beyond.
DitchCarbon Score
How does HempMeds Brasil's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HempMeds Brasil's score of 8 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HempMeds Brasil's reported carbon emissions
HempMeds Brasil currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Medical Marijuana, Inc., which may influence its sustainability practices and reporting. As of now, HempMeds Brasil has not established any documented reduction targets or climate pledges. This lack of specific commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of the industry, it is essential for HempMeds Brasil to align with broader climate initiatives and consider setting science-based targets to reduce its carbon footprint in the future. The absence of emissions data and reduction initiatives highlights an opportunity for the company to enhance its environmental accountability and contribute positively to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HempMeds Brasil is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
